568 related articles for article (PubMed ID: 29398132)
1. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
Nowak N; Skupien J; Smiles AM; Yamanouchi M; Niewczas MA; Galecki AT; Duffin KL; Breyer MD; Pullen N; Bonventre JV; Krolewski AS
Kidney Int; 2018 May; 93(5):1198-1206. PubMed ID: 29398132
[TBL] [Abstract][Full Text] [Related]
2. Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.
Yamanouchi M; Skupien J; Niewczas MA; Smiles AM; Doria A; Stanton RC; Galecki AT; Duffin KL; Pullen N; Breyer MD; Bonventre JV; Warram JH; Krolewski AS
Kidney Int; 2017 Jul; 92(1):258-266. PubMed ID: 28396115
[TBL] [Abstract][Full Text] [Related]
3. Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease.
Satirapoj B; Dispan R; Radinahamed P; Kitiyakara C
BMC Nephrol; 2018 Sep; 19(1):246. PubMed ID: 30241508
[TBL] [Abstract][Full Text] [Related]
4. Urine haptoglobin levels predict early renal functional decline in patients with type 2 diabetes.
Bhensdadia NM; Hunt KJ; Lopes-Virella MF; Michael Tucker J; Mataria MR; Alge JL; Neely BA; Janech MG; Arthur JM;
Kidney Int; 2013 Jun; 83(6):1136-43. PubMed ID: 23536133
[TBL] [Abstract][Full Text] [Related]
5. Measuring urinary tubular biomarkers in type 2 diabetes does not add prognostic value beyond established risk factors.
Conway BR; Manoharan D; Manoharan D; Jenks S; Dear JW; McLachlan S; Strachan MW; Price JF
Kidney Int; 2012 Oct; 82(7):812-8. PubMed ID: 22718188
[TBL] [Abstract][Full Text] [Related]
6. Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes.
Nowak N; Skupien J; Niewczas MA; Yamanouchi M; Major M; Croall S; Smiles A; Warram JH; Bonventre JV; Krolewski AS
Kidney Int; 2016 Feb; 89(2):459-67. PubMed ID: 26509588
[TBL] [Abstract][Full Text] [Related]
7. Systolic blood pressure as a predictor of incident albuminuria and rapid renal function decline in type 2 diabetic patients.
Sheen YJ; Lin JL; Li TC; Bau CT; Sheu WH
J Diabetes Complications; 2014; 28(6):779-84. PubMed ID: 25219331
[TBL] [Abstract][Full Text] [Related]
8. Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.
Malhotra R; Katz R; Jotwani V; Ambrosius WT; Raphael KL; Haley W; Rastogi A; Cheung AK; Freedman BI; Punzi H; Rocco MV; Ix JH; Shlipak MG
Clin J Am Soc Nephrol; 2020 Mar; 15(3):349-358. PubMed ID: 32111704
[TBL] [Abstract][Full Text] [Related]
9. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients.
Żyłka A; Dumnicka P; Kuśnierz-Cabala B; Gala-Błądzińska A; Ceranowicz P; Kucharz J; Ząbek-Adamska A; Maziarz B; Drożdż R; Kuźniewski M
Mediators Inflamm; 2018; 2018():7659243. PubMed ID: 30158836
[TBL] [Abstract][Full Text] [Related]
10. Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients With Type 2 Diabetes With and Without Albuminuria.
Ihara K; Skupien J; Kobayashi H; Md Dom ZI; Wilson JM; O'Neil K; Badger HS; Bowsman LM; Satake E; Breyer MD; Duffin KL; Krolewski AS
Diabetes Care; 2020 Nov; 43(11):2760-2767. PubMed ID: 32887710
[TBL] [Abstract][Full Text] [Related]
11. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
[TBL] [Abstract][Full Text] [Related]
12. Albuminuria and reduced glomerular filtration rate for predicting the renal outcomes in type 2 diabetic patients.
Tanaka N; Babazono T; Takagi M; Yoshida N; Toya K; Nyumura I; Hanai K; Uchigata Y
Nephrology (Carlton); 2015 Aug; 20(8):531-8. PubMed ID: 25773273
[TBL] [Abstract][Full Text] [Related]
13. Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.
Shimizu M; Furuichi K; Toyama T; Funamoto T; Kitajima S; Hara A; Ogawa D; Koya D; Ikeda K; Koshino Y; Kurokawa Y; Abe H; Mori K; Nakayama M; Konishi Y; Samejima KI; Matsui M; Yamauchi H; Gohda T; Fukami K; Nagata D; Yamazaki H; Yuzawa Y; Suzuki Y; Fujimoto S; Maruyama S; Kato S; Naito T; Yoshimura K; Yokoyama H; Wada T;
Clin Exp Nephrol; 2018 Apr; 22(2):377-387. PubMed ID: 28889347
[TBL] [Abstract][Full Text] [Related]
14. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
[TBL] [Abstract][Full Text] [Related]
15. Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy.
Tam FW; Riser BL; Meeran K; Rambow J; Pusey CD; Frankel AH
Cytokine; 2009 Jul; 47(1):37-42. PubMed ID: 19409809
[TBL] [Abstract][Full Text] [Related]
16. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
[TBL] [Abstract][Full Text] [Related]
17. Maximum home blood pressure is a useful indicator of diabetic nephropathy in patients with type 2 diabetes mellitus: KAMOGAWA-HBP study.
Oyabu C; Ushigome E; Matsumoto S; Tanaka T; Hasegawa G; Nakamura N; Ohnishi M; Tsunoda S; Ushigome H; Yokota I; Tanaka M; Asano M; Yamazaki M; Fukui M
Diab Vasc Dis Res; 2017 Nov; 14(6):477-484. PubMed ID: 28819987
[TBL] [Abstract][Full Text] [Related]
18. Association of Urinary Biomarkers of Inflammation, Injury, and Fibrosis with Renal Function Decline: The ACCORD Trial.
Nadkarni GN; Rao V; Ismail-Beigi F; Fonseca VA; Shah SV; Simonson MS; Cantley L; Devarajan P; Parikh CR; Coca SG
Clin J Am Soc Nephrol; 2016 Aug; 11(8):1343-1352. PubMed ID: 27189318
[TBL] [Abstract][Full Text] [Related]
19. Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers.
Ivory SE; Packham DK; Reutens AT; Wolfe R; Rohde RD; Lewis J; Atkins RC;
Nephrology (Carlton); 2013 Jul; 18(7):516-24. PubMed ID: 23506627
[TBL] [Abstract][Full Text] [Related]
20. Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease.
Wu L; Li XQ; Chang DY; Zhang H; Li JJ; Wu SL; Zhang LX; Chen M; Zhao MH
Nephrol Dial Transplant; 2020 Feb; 35(2):291-297. PubMed ID: 30357416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
